{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:32:07Z","timestamp":1790839927774,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n            <jats:title>Background\/Purpose:<\/jats:title>\n            <jats:p>To apply an automated deep learning automated fluid algorithm on data from real-world management of patients with neovascular age-related macular degeneration for quantification of intraretinal\/subretinal fluid volumes in optical coherence tomography images.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Data from the Vienna Imaging Biomarker Eye Study (VIBES, 2007\u20132018) were analyzed. Databases were filtered for treatment-naive neovascular age-related macular degeneration with a baseline optical coherence tomography and at least one follow-up and 1,127 eyes included. Visual acuity and optical coherence tomography at baseline, Months 1 to 3\/Years 1 to 5, age, sex, and treatment number were included. Artificial intelligence and certified manual grading were compared in a subanalysis of 20%. Main outcome measures were fluid volumes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Intraretinal\/subretinal fluid volumes were maximum at baseline (intraretinal fluid: 21.5\/76.6\/107.1 nL; subretinal fluid 13.7\/86\/262.5 nL in the 1\/3\/6-mm area). Intraretinal fluid decreased to 5 nL at M1-M3 (1-mm) and increased to 11 nL (Y1) and 16 nL (Y5). Subretinal fluid decreased to a mean of 4 nL at M1-M3 (1-mm) and remained stable below 7 nL until Y5. Intraretinal fluid was the only variable that reflected VA change over time. Comparison with human expert readings confirmed an area under the curve of &gt;0.9.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The Vienna Fluid Monitor can precisely quantify fluid volumes in optical coherence tomography images from clinical routine over 5 years. Automated tools will introduce precision medicine based on fluid guidance into real-world management of exudative disease, improving clinical outcomes while saving resources.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003557","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T21:00:14Z","timestamp":1657141214000},"page":"1673-1682","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":35,"title":["VALIDATION OF AN AUTOMATED FLUID ALGORITHM ON REAL-WORLD DATA OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION OVER FIVE YEARS"],"prefix":"10.1097","volume":"42","author":[{"given":"Bianca S.","family":"Gerendas","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Optometry, Medical University of Vienna, Spitalgasse, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sadeghipour","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Optometry, Medical University of Vienna, Spitalgasse, Vienna, Austria;"},{"name":"RetInSight GmbH, Elisabethstrasse, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Michl","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Optometry, Medical University of Vienna, Spitalgasse, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Goldbach","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Optometry, Medical University of Vienna, Spitalgasse, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Mylonas","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Optometry, Medical University of Vienna, Spitalgasse, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiia","family":"Gruber","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Medical University of Vienna, Spitalgasse, Vienna, Austria."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Alten","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Optometry, Medical University of Vienna, Spitalgasse, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Leingang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Optometry, Medical University of Vienna, Spitalgasse, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sacu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Optometry, Medical University of Vienna, Spitalgasse, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrvoje","family":"Bogunovic","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Optometry, Medical University of Vienna, Spitalgasse, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Optometry, Medical University of Vienna, Spitalgasse, Vienna, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305702","article-title":"Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)","volume":"98","author":"Schmidt-Erfurth","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.007","article-title":"A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration","volume":"50","author":"Schmidt-Erfurth","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ophtha.2020.06.038","article-title":"Retinal specialist versus artificial intelligence detection of retinal fluid from OCT: age-related eye disease study 2: 10-year follow-on study","volume":"128","author":"Keenan","year":"2020","journal-title":"Ophthalmology"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/IAE.0000000000000483","article-title":"Identification of fluid on optical coherence tomography by treating ophthalmologists versus a reading center in the comparison of age-related macular degeneration treatments trials","volume":"35","author":"Toth","year":"2015","journal-title":"Retina"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.ophtha.2012.06.040","article-title":"Optical coherence tomography grading reproducibility during the comparison of age-related macular degeneration treatments trials","volume":"119","author":"DeCroos","year":"2012","journal-title":"Ophthalmology"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2018.07.004","article-title":"Artificial intelligence in retina","volume":"67","author":"Schmidt-Erfurth","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ophtha.2017.10.031","article-title":"Fully automated detection and quantification of macular fluid in OCT using deep learning","volume":"125","author":"Schlegl","year":"2018","journal-title":"Ophthalmology"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","article-title":"Clinically applicable deep learning for diagnosis and referral in retinal disease","volume":"24","author":"De Fauw","year":"2018","journal-title":"Nat Med"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ophtha.2020.03.010","article-title":"Application of automated quantification of fluid volumes to anti\u2013VEGF therapy of neovascular age-related macular degeneration","volume":"127","author":"Schmidt-Erfurth","year":"2020","journal-title":"Ophthalmology"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.visres.2017.03.008","article-title":"Computational image analysis for prognosis determination in DME","volume":"139","author":"Gerendas","year":"2017","journal-title":"Vis Res"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/jamaophthalmol.2020.2457","article-title":"Quantification of fluid resolution and visual acuity gain in patients with diabetic macular edema using deep learning: a post hoc analysis of a randomized clinical trial","volume":"138","author":"Roberts","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ophtha.2020.09.025","article-title":"Quantitative analysis of OCT for neovascular age-related macular degeneration using deep learning","volume":"128","author":"Moraes","year":"2021","journal-title":"Ophthalmology"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.oret.2017.03.015","article-title":"Machine learning to analyze the prognostic value of current imaging biomarkers in neovascular age-related macular degeneration","volume":"2","author":"Schmidt-Erfurth","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/bjophthalmol-2020-317416","article-title":"Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy","volume":"106","author":"Michl","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12886-019-1208-9","article-title":"Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy\u2014a systematic approach to identify and characterize data sources","volume":"19","author":"Daien","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","article-title":"Resolving the clinical acuity categories \u201chand motion\u201d and \u201ccounting fingers\u201d using the Freiburg Visual Acuity Test (FrACT)","volume":"247","author":"Lange","year":"2009","journal-title":"Graefe's Arch Clin Exp Ophthalmo"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0000000000003385","article-title":"A systematic correlation of central subfield thickness (CSFT) with retinal fluid volumes quantified by deep learning in the major exudative macular diseases","volume":"42","author":"Pawloff","year":"2021","journal-title":"Retina"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"OCT14","DOI":"10.1167\/iovs.16-19969","article-title":"Optical coherence tomography and the development of antiangiogenic therapies in neovascular age-related macular degeneration","volume":"57","author":"Rosenfeld","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ophtha.2018.08.035","article-title":"Macular morphology and visual acuity in year five of the comparison of age-related macular degeneration treatments trials","volume":"126","author":"Jaffe","year":"2019","journal-title":"Ophthalmology"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ophtha.2015.12.002","article-title":"Macular morphology and visual acuity in the second year of the comparison of age-related macular degeneration treatments trials","volume":"123","author":"Sharma","year":"2016","journal-title":"Ophthalmology"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.preteyeres.2017.12.002","article-title":"Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors","volume":"65","author":"Mehta","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.ophtha.2020.03.034","article-title":"Poorer outcomes in real-world studies of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration","volume":"127","author":"Hsu","year":"2020","journal-title":"Ophthalmology"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ophtha.2020.02.027","article-title":"Management and outcomes for neovascular age-related macular degeneration: analysis of United States electronic health records","volume":"127","author":"Kiss","year":"2020","journal-title":"Ophthalmology"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jamaophthalmol.2021.2273","article-title":"Validation and clinical applicability of whole-volume automated segmentation of optical coherence tomography in retinal disease using deep learning","volume":"139","author":"Wilson","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.ophtha.2016.04.005","article-title":"Automated identification of lesion activity in neovascular age-related macular degeneration","volume":"123","author":"Chakravarthy","year":"2016","journal-title":"Ophthalmology"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2020.12.012","article-title":"Automated quantitative assessment of retinal fluid volumes as important biomarkers in neovascular age-related macular degeneration","volume":"224","author":"Keenan","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1109\/TMI.2019.2901398","article-title":"RETOUCH: the retinal OCT fluid detection and segmentation benchmark and challenge","volume":"38","author":"Bogunovic","year":"2019","journal-title":"IEEE Trans Med Imaging"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1097\/IAE.0000000000002670","article-title":"Ranibizumab treatment in treatment-naive neovascular age-related macular degeneration: results from luminous, a global real-world study","volume":"40","author":"Holz","year":"2020","journal-title":"Retina"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1755-3768.2012.02493.x","article-title":"Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study\u2014a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany","volume":"91","author":"Finger","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"R31-20250607","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/IAE.0b013e31827b6324","article-title":"Changes in visual acuity in patients with wet age-related macular degeneration treated with intravitreal ranibizumab in daily clinical practice: the LUMIERE study","volume":"33","author":"Cohen","year":"2013","journal-title":"Retina"},{"key":"R32-20250607","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1167\/iovs.13-11993","article-title":"Prospective audit of exudative age-related macular degeneration: 12-month outcomes in treatment-naive eyes","volume":"54","author":"Gillies","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R33-20250607","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/bjophthalmol-2015-308166","article-title":"Key drivers of visual acuity gains in neovascular age-related macular degeneration in real life: findings from the AURA study","volume":"100","author":"Holz","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"R34-20250607","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1038\/s41433-020-01354-4","article-title":"Impact of macular fluid volume fluctuations on visual acuity during anti-VEGF therapy in eyes with nAMD","volume":"35","author":"Chakravarthy","year":"2021","journal-title":"Eye"},{"key":"R35-20250607","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/jamaophthalmol.2020.3001","article-title":"Associations of variation in retinal thickness with visual acuity and anatomic outcomes in eyes with neovascular age-related macular degeneration lesions treated with anti-vascular endothelial growth factor Agents","volume":"138","author":"Evans","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"R36-20250607","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ajo.2020.06.028","article-title":"Eliminating visual acuity and dilated fundus examinations improves cost efficiency of performing optical coherence tomogrpahy\u2013guided intravitreal injections","volume":"219","author":"Trivizki","year":"2020","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:00:39Z","timestamp":1749319239000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003557","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}